Annual Scientific Symposium will take place October 23-26 in San Francisco
September 06, 2023
CRF Announces TCT 2023 Late-breaking Clinical Trials
September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical…
Read More
The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows
September 06, 2023
Large Kaiser Permanente Study Could Lead to Better Management for Patients with Aortic Stenosis
September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser…
Read More
Updated AI-based software is designed to improve cardiac ablation outcomes and procedural efficiencies
September 06, 2023
Vektor Medical Unveils Enhanced vMap Technology for Accurate, Non-invasive Mapping of Cardiac Arrhythmias
September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead …
Read More
Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.
September 06, 2023
Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump
September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device…
Read More
GE HealthCare and Mass General Brigham have announced the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity.
September 06, 2023
Mass Gen Brigham and GE HealthCare Collaboration Announces AI Algorithm, Radiology Operations Module (ROM), to Optimize Scheduling and Productivity
September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co…
Read More
Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.
September 05, 2023
Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released
September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-…
Read More
September 05, 2023
Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients
September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for…
Read More
The Ohio State University Wexner Medical Center randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
September 05, 2023
Ohio State First in World to Participate in Trial of Device Designed to Alleviate Heart Failure Symptoms
September 5, 2023 — The Ohio State University Wexner Medical Center randomized the first patient in the world in a…
Read More
Raj Makkar, MD
September 05, 2023
Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe
September 5, 2023 — Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve…
Read More
First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
September 05, 2023
BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK’s Newest Resorbable Magnesium Scaffold Resorbed at 12 Months
September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process…
Read More
CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023
August 31, 2023
Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure
August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or…
Read More
ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023
August 31, 2023
ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support
August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial…
Read More
This is the first international guideline document to include all cardiomyopathy subtypes
August 31, 2023
First International Guidelines on Heart Muscle Diseases Published
August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in …
Read More
Here's a look at what viewers found most interesting during the month of August on dicardiology.com
By Melinda Taschetta-Millane
August 31, 2023
Top 10: A Look at the Hot Topics from August
As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.…
Read More
Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023
August 30, 2023
12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT
August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro …
Read More
MULTISTARS AMI trial presented in a Hot Line session today at ESC Congress 2023
August 30, 2023
Trial Investigates Timing of Complete Revascularization for Myocardial Infarction
August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel…
Read More
August 30, 2023
Highlights from the ESC Congress 2023
August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said…
Read More
Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session at ESC Congress 2023
August 29, 2023
Optical Coherence Tomography Non-inferior to Intravascular Ultrasound for Stent Guidance
August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding…
Read More
The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.
August 29, 2023
First ESC Guidelines Covering All Acute Coronary Syndromes Published
August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online…
Read More
Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement
August 29, 2023
Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases
August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV)…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now